Details

Digitalna transformacija medorganizacijskega tržnega komuniciranja : magistrsko delo
ID Vraničar, Žiga (Author), ID Kline, Miro (Mentor) More about this mentor... This link opens in a new window

URLURL - Presentation file, Visit http://dk.fdv.uni-lj.si/magistrska/pdfs/mag_vranicar-ziga.pdf This link opens in a new window

Language:Slovenian
Keywords:digitalna transformacija, medorganizacijski trgi, Trženje, Tržno komuniciranje, Digitalizacija, Magistrske naloge
Work type:Master's thesis
Typology:2.09 - Master's Thesis
Organization:FDV - Faculty of Social Sciences
Place of publishing:Ljubljana
Publisher:[Ž. Vraničar]
Year:2016
Number of pages:99 str.
PID:20.500.12556/RUL-87745 This link opens in a new window
UDC:339.138(043)
COBISS.SI-ID:34494557 This link opens in a new window
Publication date in RUL:13.12.2016
Views:3366
Downloads:317
Metadata:XML DC-XML DC-RDF
:
VRANIČAR, Žiga, 2016, Digitalna transformacija medorganizacijskega tržnega komuniciranja : magistrsko delo [online]. Master’s thesis. Ljubljana : Ž. Vraničar. [Accessed 8 June 2025]. Retrieved from: http://dk.fdv.uni-lj.si/magistrska/pdfs/mag_vranicar-ziga.pdf
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Keywords:Marketing, Marketing communication, Digitization, Master's theses

Similar documents

Similar works from RUL:
  1. Pregled zdravljenja bolnikov z napredovalnim nedrobnoceličnim pljučnim rakom z mutacijami v receptorju za epidermalni rastni dejavnik med leti 2010 in 2014 na Univerzitetni kliniki Golnik
  2. Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč
  3. Raziskava možnosti racionalizacije režima odmerjanja pembrolizumaba pri zdravljenju napredovalega nedrobnoceličnega raka pljuč
Similar works from other Slovenian collections:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Back